Literature DB >> 11705738

Effects of glutamine deprivation on protein synthesis in a model of human enterocytes in culture.

O Le Bacquer1, H Nazih, H Blottière, D Meynial-Denis, C Laboisse, D Darmaun.   

Abstract

To assess the effect of glutamine availability on rates of protein synthesis in human enterocytes, Caco-2 cells were grown until differentiation and then submitted to glutamine deprivation produced by exposure to glutamine-free medium or methionine sulfoximine [L-S-[3-amino-3-carboxypropyl]-S-methylsulfoximine (MSO)], a glutamine synthetase inhibitor. Cells were then incubated with (2)H(3)-labeled leucine with or without glutamine, and the fractional synthesis rate (FSR) of total cell protein was determined from (2)H(3)-labeled enrichments in protein-bound and intracellular free leucine measured by gas chromatography-mass spectrometry. Both protein FSR (28 +/- 1.5%/day) and intracellular glutamine concentration (6.1 +/- 0.6 micromol/g protein) remained unaltered when cells were grown in glutamine-free medium. In contrast, MSO treatment resulted in a dramatic reduction in protein synthesis (4.6 +/- 0.6 vs. 20.2 +/- 0.8%/day, P < 0.01). Supplementation with 0.5-2 mM glutamine for 4 h after MSO incubation, but not with glycine nor glutamate, restored protein FSR to control values (24 +/- 1%/day). These results demonstrate that in Caco-2 cells, 1) de novo glutamine synthesis is highly active, since it can maintain intracellular glutamine pool during glutamine deprivation, 2) inhibition of glutamine synthesis is associated with reduced protein synthesis, and 3) when glutamine synthesis is depressed, exogenous glutamine restores normal intestinal FSR. Due to the limitations intrinsic to the use of a cell line as an experimental model, the physiological relevance of these findings for the human intestine in vivo remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705738     DOI: 10.1152/ajpgi.2001.281.6.G1340

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  8 in total

1.  New insights in nutritional management and amino acid supplementation in urea cycle disorders.

Authors:  Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2010-03-01       Impact factor: 4.797

2.  Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy.

Authors:  Danny Alexander; Raffaella Lombardi; Gabriela Rodriguez; Matthew M Mitchell; Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-12-14       Impact factor: 4.686

3.  The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line.

Authors:  Wyatt J Roth; David J Lindley; Stephen M Carl; Gregory T Knipp
Journal:  J Pharm Sci       Date:  2012-07-11       Impact factor: 3.534

4.  Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans.

Authors:  Olivier Le Bacquer; Nelly Mauras; Susan Welch; Morey Haymond; Dominique Darmaun
Journal:  Clin Nutr       Date:  2006-11-13       Impact factor: 7.324

5.  Enteral glutamine supplementation and dexamethasone attenuate the local intestinal damage in rats with experimental necrotizing enterocolitis.

Authors:  Alaeddin Dilsiz; Ilhan Ciftçi; T Murad Aktan; Mehmet Gürbilek; Emrah Karagözoğlu
Journal:  Pediatr Surg Int       Date:  2003-10-11       Impact factor: 1.827

Review 6.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

7.  Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate.

Authors:  E C Clark; S D Patel; P R Chadwick; G Warhurst; A Curry; G L Carlson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

8.  Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts.

Authors:  Daniela Gaglio; Chiara Soldati; Marco Vanoni; Lilia Alberghina; Ferdinando Chiaradonna
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.